EcoDrugPlus

Cholinergic Receptor Nicotinic Beta 4 Subunit

Ensembl ID : ENSBMSG00010013876
Gene Symbol: CHRNB4
1 Cross references
199 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor

Ensembl ID : ENSBMSG00010005694
Gene Symbol: F2R
1 Cross references
330 Possible Orthologues:

Coagulation Factor Ii, Thrombin

Ensembl ID : ENSBMSG00010017325
Gene Symbol: F2
1 Cross references
86 Possible Orthologues:

Coagulation Factor Iii, Tissue Factor

Ensembl ID : ENSBMSG00010001415
Gene Symbol: F3
1 Cross references
246 Possible Orthologues:

Coagulation Factor Vii

Ensembl ID : ENSBMSG00010019994
Gene Symbol: F7
1 Cross references
203 Possible Orthologues:

Coagulation Factor Xi

Ensembl ID : ENSBMSG00010021926
Gene Symbol: F11
1 Cross references
215 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSBMSG00010013722
Gene Symbol: CCDC6
1 Cross references
223 Possible Orthologues:

Colony Stimulating Factor 1 Receptor

Ensembl ID : ENSBMSG00010001379
Gene Symbol: CSF1R
1 Cross references
273 Possible Orthologues:

Complement C1s

Ensembl ID : ENSBMSG00010016127
Gene Symbol: C1S
1 Cross references
199 Possible Orthologues:

Complement C5

Ensembl ID : ENSBMSG00010000396
Gene Symbol: C5
1 Cross references
212 Possible Orthologues:

Complement Factor D

Ensembl ID : ENSBMSG00010000491
Gene Symbol: CFD
1 Cross references
134 Possible Orthologues:

Corticotropin Releasing Hormone Receptor 1

Ensembl ID : ENSBMSG00010019636
Gene Symbol: CRHR1
1 Cross references
208 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).